Precise Biometrics, a leader in fingerprint software, has entered into a commercial software license and distribution agreement with Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, for the licensing of Precise Biometrics’ algorithm solution for fingerprint recognition, Precise BioMatch Mobile. This agreement includes (i) a per unit license fee, as well as an annual fee, pertaining to the use of Precise BioMatch Mobile based on actual sales of certain fingerprint sensors utilizing said technology, and (ii) an annual fee for support and maintenance. While the per unit license fee is volume dependent and cannot be forecasted by Precise at this point, Precise is currently projecting that some of the revenue generated under the agreement will be recognized starting from the third quarter of 2016. “We are delighted to enter into this commercial software license and distribution agreement with Qualcomm Technologies, Inc., a leader in the mobile industry, which will help further strengthen our position as a leader in fingerprint software. We look forward to working together and supporting Qualcomm Technologies with their fingerprint solutions,” said Håkan Persson, CEO of Precise Biometrics. Precise BioMatch Mobile (http://precisebiometrics.com/fingerprint -technology/precise-biomatch-mobile/) is the industry’s leading algorithm solution for convenient and secure fingerprint recognition in smartphones and tablets. The unique and patented hybrid algorithm solution is optimized for small fingerprint sensors and platforms with limited processing power and memory. Precise BioMatch Mobile offers fast, accurate, and secure verification of user’s identity, creating a convenient user experience when unlocking mobile devices or authenticating to services. This information is information that Precise Biometrics AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 8.00 CEST on July 28, 2016. FOR FURTHER INFORMATION, PLEASE CONTACT Håkan Persson, CEO, Precise Biometrics AB Phone; +46 46 31 11 05 or +46 734 35 11 05 E-mail; hakan.persson@precisebiometrics.com ABOUT PRECISE BIOMETRICS Precise Biometrics is a market leading supplier of solutions for convenient and secure authentication of people’s identity. We develop and sell fingerprint software and mobile smart card readers that provide the market’s best user experience and security. Our solutions are used hundreds of millions of times every day by people all over the world and are marketed together with strong business partners. For more information, please visit; http://precisebiometrics.com/ ### * Qualcomm is a trademark of Qualcomm Incorporated, registered in the United States and other countries.
Precise Biometrics enters into agreement with Qualcomm
Top 10 Most Recent News Articles
Terminus Ballet: A Decade of Defying Dance Norms
A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...
Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?
Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...
Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights
Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...
Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves
Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...
Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline
Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....
Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain
New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...
Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment
Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...
Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing
Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...
Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo
ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...
Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola
New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...
Continue ReadingTop 5 Most Recently Viewed Articles
Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations
Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....
Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS
Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...
Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.
Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...
Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results
Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...
Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery
Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...
Continue Reading